EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk
I. M. Wilson, E. A. Vucic, K. S.S. Enfield, K. L. Thu, Y. A. Zhang, R. Chari, W. W. Lockwood, N. Radulovich, D. T. Starczynowski, J. P. Banáth, M. Zhang, A. Pusic, M. Fuller, K. M. Lonergan, D. Rowbotham, J. Yee, J. C. English, T. P.H. Buys, S. A. Selamat, I. A. Laird-OffringaP. Liu, M. Anderson, M. You, M. S. Tsao, C. J. Brown, K. L. Bennewith, C. E. MacAulay, A. Karsan, A. F. Gazdar, S. Lam, W. L. Lam
Dive into the research topics of 'EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science